ArticleJournal of experimental orthopaedics2026
Comparable outcomes in male and female patients undergoing periacetabular osteotomy.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of tranexamic acid use and autologous predonation with blood loss and transfusion outcomes after periacetabular osteotomy: An arm-based multilevel meta analysis.Journal of experimental orthopaedics · 2026Review
- Does travel distance influence short-term outcome after periacetabular osteotomy?-A cohort study.Journal of experimental orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Periacetabular osteotomy (PAO) is an established treatment for DDH with generally favourable outcomes. Although developmental hip dysplasia (DDH) is more prevalant in females, it remains unclear whether male patients achieve comparable patient reported outcome, with some studies suggesting inferior outcome in men. The aim of this study was to evaluate short-term outcomes of PAO in male versus female hips. Methods: A prospective PAO registry was utilized and predefined inclusion criteria applied. A total of 282 hips (44 male, 238 female) that had undergone PAO surgery between 2022 and 2024 by a single surgeon were included. Radiographic measures and patient-reported outcome measures (PROMs), including the University of California, Los Angeles activity scale (UCLA), Hip Disability and Osteoarthritis Outcome Score - Physical Function Shortform (HOOS-PS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), international hip outcome tool-12 (iHOT-12), Harris hip score (HHS), modified Harris Hip Score (mHHS) and Postel-Merle d'Aubigné (PMA) score, were assessed preoperatively and at final follow-up and compared between sexes. Results: Preoperatively, male patients had higher BMI (27.07 vs. 25.01, Conclusion: The findings of this study demonstrate that there are no significant sex-related differences in the clinical burden of DDH or in short-term outcomes after PAO in patients with this diagnosis. Both males and females showed substantial improvement after PAO, indicating that the procedure provides similarly favourable outcomes for both sexes. Based on these results, gender should not influence decision-making in PAO surgery. Level of Evidence: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.